Estée Lauder Unveils Mastering Skin Longevity Platform at China Import Expo
Estée Lauder Companies has launched its Mastering Skin Longevity scientific platform at the China International Import Expo.

Estée Lauder Companies unveiled its Mastering Skin Longevity platform at the China International Import Expo in Shanghai. The event ran from November 5 to 10. This scientific platform is designed to advance integrated research on skin ageing and longevity across the company's brand portfolio.
Stéphane de La Faverie, ELC’s President and CEO, stated that the launch marks a significant step. "Mastering skin longevity reflects how we are advancing the next era of skin science and innovation across our brand portfolio," he said. The company chose China for the reveal, citing it as a market at the forefront of scientific and consumer innovation.
Scientific foundation for brand portfolio
The new platform will serve as a shared scientific foundation for ELC’s diverse brand portfolio. This includes brands like The Ordinary, Clinique, and Dr.Jart+. By studying biological systems together, ELC aims to create a more integrated foundation for discovery. This approach is expected to identify new opportunities in ingredients, technologies, formulations, and products. The overarching target is the Master Regulators of Skin Longevity, which support cellular repair, resilience, and regeneration.
Focus on master regulators of skin longevity
Moving beyond individual hallmarks of aging, the platform focuses on interconnected master regulators. These are biological pathways and proteins that influence multiple signs of ageing simultaneously. Key regulators include sirtuins, AMP-activated protein kinase (AMPK), and the mechanistic target of rapamycin (mTOR). René Lammers, Executive VP and Chief Research & Innovation Officer at ELC, explained the distinction. He noted that while hallmarks of ageing help understand skin changes, master regulators help investigate the biological systems influencing those changes.
Brand-specific applications
Each brand under the ELC umbrella will apply the platform's research to its core strengths. The applications will be tailored to each brand's established expertise and consumer base.
ELC introduced a comprehensive scientific white paper alongside the platform. This document outlines the company's perspective on the evolution of skin longevity science. The research is informed by scientists and a Longevity Scientific Advisory Board with members from China, Singapore, and the US. ELC is advancing this work through its Longevity Labs in New York and Shanghai.
The launch aligns with ELC's broader corporate momentum. The company recently raised its fiscal year 2027 outlook following a first-quarter sales boost. Its growth strategy includes helping acquired independent brands thrive. Notably, The Ordinary is projected to reach nearly $1 billion in sales, a trajectory integrated into ELC's 2030 growth plans.





